Evidence map›Paper›PMID 35870810›Full record

ArticleKidney international2022

Heparin, klotho, and FGF23: the 3-beat waltz of the discordant heart.

Marta Martinez-Calle, Valentin David

Abstract readComment
PubMed Publisher
In one paragraph

Article in Kidney international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marta Martinez-CalleDivision of Nephrology and Hypertension, Department of Medicine, and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Valentin DavidDivision of Nephrology and Hypertension, Department of Medicine, and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address: valentin.david@northwestern.edu.
Northwestern University · US

Funding

Regulation of FGF23 in Chronic Kidney Disease (CKD) by iron and inflammationR01DK102815 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DAVID, NICOLAE VALENTIN · 2015 to 2024
$4.9M
Role of FGF23 peptides in chronic kidney disease (CKD)R01DK132657 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Nicolae Valentin David · 2023 to 2026
$2.6M
Role of HNF4a in the regulation of FGF23 in health and diseaseR01DK114158 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DAVID, NICOLAE VALENTIN · 2018 to 2021
$1.6M
NIDDK NIH HHS R01 DK102815NIDDK NIH HHS R01 DK114158
6 · The paper itself

Abstract

Excess fibroblast growth factor (FGF) 23 signaling in patients with chronic kidney disease induces left ventricular hypertrophy. In this issue, Yanucil et al. investigated the interaction of soluble klotho and heparin with FGF23 and FGF receptor isoforms. They concluded that heparin promotes the FGF23-FGF receptor isoform 4 interaction and FGF23 pathogenic effects, supporting an important role of heparin in the pathogenesis of FGF23-mediated left ventricular hypertrophy in chronic kidney disease.

Indexed as

GlucuronidaseRenal Insufficiency, ChronicFibroblast Growth FactorsHeparinHumansHydrolasesHypertrophy, Left VentricularKlotho ProteinsReceptor, Fibroblast Growth Factor, Type 4Receptors, Fibroblast Growth FactorFibroblast Growth FactorsGlucuronidaseHeparinHydrolasesKlotho ProteinsReceptor, Fibroblast Growth Factor, Type 4Receptors, Fibroblast Growth Factor

Identifiers

PMID35870810
OpenAlexW4285992563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.